“Time-to-Efficacy Outcomes by Observed Abrocitinib Dosing Patterns Among Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE REAL”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 3, May 2026, p. s777, https://doi.org/10.25251/g9yw0x36.